Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
BioPharm
Sponsored by Cytiva
Biopharma Trends
Upstream
Downstream
Regulatory/QbD
Articles
Subscribe to Enews
Share This Page
Email
Facebook
Twitter
October 20, 2022
Scaling a mAb production process to Xcellerex bioreactors
Cytiva
Moving a monoclonal antibody production process from a microscale bioreactor to the Xcellerex XDR single-use platform.
READ MORE >>
Related Content
Innovations in Cell Culture: Manufacturing the Future
Cell Culture Media Considerations and Optimization for Improved Titers and Protein Quality
Developing a Continuous Large-Scale Perfusion Cell Culture Process
Balancing innovation, speed, and robustness to improve efficiency in upstream process development.
Innovations in Cell Culture: Developing the Future
See All Articles…
